Janeen Noel Doyle - 14 May 2025 Form 3 Insider Report for Janux Therapeutics, Inc. (JANX)

Signature
/s/ James Pennington, Attorney-in-Fact
Issuer symbol
JANX
Transactions as of
14 May 2025
Net transactions value
$0
Form type
3
Filing time
23 May 2025, 20:02:57 UTC
Next filing
04 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr C/O JANUX THERAPEUTICS, INC., 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO /s/ James Pennington, Attorney-in-Fact 23 May 2025 0002069239

No securities are beneficially owned.